09 de julio de 2018
Korea finished drug market growth driven by generics
Amsterdam, 9th July 2018: The Korean pharma market is experiencing significant growth in finished drug products, according to CPhI Korea. Over the last 12 months, market conditions have spurred a strong expansion in exports of finished formulations, driven primarily by an expanding domestic generics market.
05 de julio de 2018
CPhI Worldwide opens entries for 15th Annual Pharma Awards
Amsterdam, 2nd July 2018 : CPhI Worldwide – organised by UBM (part of Informa PLC) – announces the opening of the 2018 CPhI Pharma Awards for entries. The industry’s preeminent awards return for a landmark 15th edition, with 17 categories honouring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies.
11 de junio de 2018
Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital
Amsterdam, 11 June 2018: CPhI & P-MEC India (December 10-14, 2018) – organised by UBM – announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1,500 exhibitors.
04 de junio de 2018
‘Process innovation needs to be undertaken in early R&D phase’ – predicts ADC Bio
4 June 2018, Wales: ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and streamline production processes of ADCs will be designed at the clinical development stage by specialist, ADC focused service providers. At present, a number of the larger CDMOsare focused solely on commercial scale ADC production and lack both the bandwidth and motivation for innovative manufacturing methods.